Chart Review And Exploration Of Sustaining Remission In Major Depressive Disorder

For patients with major depressive disorder (MDD), achieving remission is the penultimate therapeutic goal. Still, many patients treated with the standard initial treatment do not achieve a full and durable response. Rather, they are at high risk for residual and recurrent symptoms, treatment-resistance, and relapse.(1) This neuroscienceCME Chart Review activity addresses clinician-based gaps that may contribute to suboptimal rates of long-term, sustained remission among patients with MDD. Specifically, an index patient case will be used as the content foundation upon which expert faculty will engage in a provocative, consult-type exchange.